Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical tools, announced a research collaboration with Soin ...
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced a milestone patient revision from a traditional sacral neuromodulation ...
During the panel discussion with behavioral health experts, Cavanagh, speaking in his role at Restore Brain, addressed one of ...
Boston Scientific executive discusses $533M Nalu Medical acquisition strategy and plans for peripheral nerve stimulation ...
Brain-Stimulation Tools Once Limited to Researchers Are Now Reaching the Public at Home Through a First-of-Its-Kind ...
Please provide your email address to receive an email when new articles are posted on . Artificial tears have long been the first option for patients with dry eye disease, but they only offer a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results